Kwa M[au] - Search Results

Year	Number of Results
1992	1
1993	3
1994	1
1995	1
1996	1
1998	2
1999	1
2001	2
2003	3
2009	1
2011	1
2012	2
2013	3
2014	5
2015	2
2016	6
2017	9
2018	12
2019	3
2020	5
2021	4
2022	7
2023	2

1

The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Kwa M, Plottel CS, Blaser MJ, Adams S. Kwa M, et al. J Natl Cancer Inst. 2016 Apr 22;108(8):djw029. doi: 10.1093/jnci/djw029. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27107051 Free PMC article. Review.

2

Janus kinase inhibitors in dermatology: Part I. A comprehensive review.

Chapman S, Kwa M, Gold LS, Lim HW. Chapman S, et al. Among authors: kwa m. J Am Acad Dermatol. 2022 Feb;86(2):406-413. doi: 10.1016/j.jaad.2021.07.002. Epub 2021 Jul 8. J Am Acad Dermatol. 2022. PMID: 34246698 Review.

3

Regulation of Cosmetics.

Janetos TM, Kwa M, Xu S. Janetos TM, et al. Among authors: kwa m. JAMA Intern Med. 2018 Jul 1;178(7):1000-1001. doi: 10.1001/jamainternmed.2018.2452. JAMA Intern Med. 2018. PMID: 29971363 No abstract available.

4

Cancer-associated fibroblasts: how do they contribute to metastasis?

Kwa MQ, Herum KM, Brakebusch C. Kwa MQ, et al. Clin Exp Metastasis. 2019 Apr;36(2):71-86. doi: 10.1007/s10585-019-09959-0. Epub 2019 Mar 7. Clin Exp Metastasis. 2019. PMID: 30847799 Review.

5

Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach.

Purswani JM, Hardy-Abeloos C, Perez CA, Kwa MJ, Chadha M, Gerber NK. Purswani JM, et al. Among authors: kwa mj. Curr Oncol. 2022 Dec 23;30(1):184-195. doi: 10.3390/curroncol30010015. Curr Oncol. 2022. PMID: 36661664 Free PMC article. Review.

6

Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here.

Kwa MJ, Adams S. Kwa MJ, et al. Cancer. 2018 May 15;124(10):2086-2103. doi: 10.1002/cncr.31272. Epub 2018 Feb 9. Cancer. 2018. PMID: 29424936 Free article. Review.

7

Clinical utility of gene-expression signatures in early stage breast cancer.

Kwa M, Makris A, Esteva FJ. Kwa M, et al. Nat Rev Clin Oncol. 2017 Oct;14(10):595-610. doi: 10.1038/nrclinonc.2017.74. Epub 2017 May 31. Nat Rev Clin Oncol. 2017. PMID: 28561071 Review.

8

[Side effects of medicinal products: assessment and registration of causality].

Machiels JD, Vries MJA, Kwa MSG, Voskamp L, van Puijenbroek EP, Kramers C. Machiels JD, et al. Among authors: kwa msg. Ned Tijdschr Geneeskd. 2022 May 5;166:D6199. Ned Tijdschr Geneeskd. 2022. PMID: 35736375 Dutch.

9

Commentary on: "Oxybenzone and pregnancy: Time for more research and patient education".

Kwa MC, Lim HW. Kwa MC, et al. J Am Acad Dermatol. 2022 May;86(5):e215. doi: 10.1016/j.jaad.2021.12.011. Epub 2021 Dec 14. J Am Acad Dermatol. 2022. PMID: 34920030 No abstract available.

10

Allergen Concerns and Popular Skin Care Products-Reply.

Xu S, Kwa M, Silverberg JI. Xu S, et al. Among authors: kwa m. JAMA Dermatol. 2018 Jan 1;154(1):115-116. doi: 10.1001/jamadermatol.2017.5000. JAMA Dermatol. 2018. PMID: 29188272 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results